Ballentine Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.4M | Sell |
3,664
-399
| -10% | -$153K | 0.02% | 262 |
|
2025
Q1 | $1.4M | Sell |
4,063
-6
| -0.1% | -$2.07K | 0.02% | 236 |
|
2024
Q4 | $1.22M | Sell |
4,069
-44
| -1% | -$13.2K | 0.02% | 246 |
|
2024
Q3 | $1.67M | Buy |
4,113
+107
| +3% | +$43.5K | 0.03% | 198 |
|
2024
Q2 | $1.29M | Buy |
4,006
+127
| +3% | +$40.8K | 0.02% | 219 |
|
2024
Q1 | $1.29M | Buy |
3,879
+38
| +1% | +$12.7K | 0.02% | 203 |
|
2023
Q4 | $1.04M | Buy |
3,841
+675
| +21% | +$183K | 0.02% | 223 |
|
2023
Q3 | $779K | Sell |
3,166
-18
| -0.6% | -$4.43K | 0.02% | 231 |
|
2023
Q2 | $966K | Buy |
3,184
+81
| +3% | +$24.6K | 0.02% | 201 |
|
2023
Q1 | $818K | Buy |
3,103
+124
| +4% | +$32.7K | 0.02% | 222 |
|
2022
Q4 | $715K | Sell |
2,979
-26
| -0.9% | -$6.24K | 0.02% | 225 |
|
2022
Q3 | $553K | Buy |
3,005
+439
| +17% | +$80.8K | 0.02% | 231 |
|
2022
Q2 | $431K | Buy |
2,566
+38
| +2% | +$6.38K | 0.02% | 260 |
|
2022
Q1 | $634K | Buy |
2,528
+51
| +2% | +$12.8K | 0.02% | 228 |
|
2021
Q4 | $637K | Hold |
2,477
| – | – | 0.02% | 236 |
|
2021
Q3 | $601K | Buy |
2,477
+18
| +0.7% | +$4.37K | 0.02% | 212 |
|
2021
Q2 | $508K | Buy |
2,459
+6
| +0.2% | +$1.24K | 0.02% | 231 |
|
2021
Q1 | $462K | Sell |
2,453
-118
| -5% | -$22.2K | 0.02% | 233 |
|
2020
Q4 | $423K | Sell |
2,571
-396
| -13% | -$65.2K | 0.02% | 235 |
|
2020
Q3 | $370K | Buy |
2,967
+390
| +15% | +$48.6K | 0.02% | 249 |
|
2020
Q2 | $250K | Sell |
2,577
-61
| -2% | -$5.92K | 0.01% | 309 |
|
2020
Q1 | $238K | Buy |
2,638
+144
| +6% | +$13K | 0.01% | 288 |
|
2019
Q4 | $368K | Sell |
2,494
-5
| -0.2% | -$738 | 0.02% | 267 |
|
2019
Q3 | $301K | Sell |
2,499
-102
| -4% | -$12.3K | 0.01% | 291 |
|
2019
Q2 | $351K | Buy |
2,601
+1,004
| +63% | +$135K | 0.02% | 265 |
|
2019
Q1 | $209K | Buy |
+1,597
| New | +$209K | 0.01% | 305 |
|
2018
Q4 | – | Sell |
-1,603
| Closed | -$222K | – | 348 |
|
2018
Q3 | $222K | Buy |
+1,603
| New | +$222K | 0.01% | 314 |
|